Caxton Associates (New York)’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
CIP
N
Caxton Associates (New York)'s PBH Position: Q1 2020 in Review
Caxton Associates (New York) sold out of Prestige Consumer Healthcare (PBH) in Q1 2020, closing a stake of 8,563 shares — an estimated $347K sold.
Caxton Associates (New York) first reported a position in PBH in Q4 2019 and held it in 1 quarter. The position peaked at $347K in Q4 2019. 251 funds tracked by Wall St. Rank hold PBH as of Q1 2020.
- Caxton Associates (New York) reported no remaining Prestige Consumer Healthcare position as of Q1 2020 after selling out during the quarter.
- Caxton Associates (New York) sold 8,563 Prestige Consumer Healthcare shares in Q1 2020, an estimated $347K.
- Caxton Associates (New York) first reported a position in Prestige Consumer Healthcare in Q4 2019 and held it in 1 quarter.
- Caxton Associates (New York)'s Prestige Consumer Healthcare position peaked at $347K in Q4 2019.
- 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2020.
Based on Caxton Associates (New York)'s 13F filing for Q1 2020, filed 15 May 2020.